We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. Show more
CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
First-Ever Open IND for Prime Editing Technology PM359 is Prime Medicine’s Ex Vivo Product Candidate Designed to Correct a Prevalent Disease-Causing Mutation of CGD Initial Data Expected in 2025...
-- Presentations include new preclinical data for PM359, further demonstrating ability of Prime Editors to efficiently, reproducibly and durably correct causative mutation of CGD; on track to...
-- Maturing into clinical-stage company; on-track to file IND application or CTA for PM359 in 1H 2024, with initial data expected in 2025 -- -- Progressing broader portfolio across core areas of...
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.4 | 8 | 5 | 6.09 | 4.6302 | 1035739 | 5.3363979 | CS |
| 4 | -0.78 | -12.6213592233 | 6.18 | 6.4 | 4.11 | 820884 | 5.08196532 | CS |
| 12 | -1.36 | -20.1183431953 | 6.76 | 9.77 | 4.11 | 793525 | 6.64044164 | CS |
| 26 | -2.37 | -30.5019305019 | 7.77 | 9.86 | 4.11 | 665276 | 7.08614575 | CS |
| 52 | -8.92 | -62.2905027933 | 14.32 | 17.2 | 4.11 | 545489 | 9.01606096 | CS |
| 156 | -13.57 | -71.5340010543 | 18.97 | 21.7301 | 4.11 | 436800 | 10.46352504 | CS |
| 260 | -13.57 | -71.5340010543 | 18.97 | 21.7301 | 4.11 | 436800 | 10.46352504 | CS |
NY1972
2 weeks ago
jondoeuk
2 weeks ago
jondoeuk
3 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
